Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Action inhibitors |
Mechanism NS3 inhibitors(Hepatitis C virus (HCV) nonstructural protein 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC56H75N11O13 |
InChIKeyUPQQGQPPFLHEMM-PDWPTQNYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | United States | 01 Aug 2019 | |
Hepatitis C | Preclinical | United States | 01 Aug 2019 |